You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 43598-0549


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 43598-0549

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
PROPOFOL 10MG/ML INJ,EMULSION Dr. Reddys Laboratories 43598-0549-10 10X100ML 66.99 2020-09-15 - 2025-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

43598-0549 Market Analysis and Financial Projection

Market Analysis and Price Projections for NDC 43598-0549: Propofol Injectable Emulsion

Overview of NDC 43598-0549

NDC 43598-0549 corresponds to Propofol Injectable Emulsion, a product manufactured by Dr. Reddy's Laboratories Inc. Propofol is a widely used anesthetic agent in medical and surgical procedures.

Market Context

Biopharma and Biotech Industry Trends

The biopharma and biotech industries are experiencing rapid growth, driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. As of 2024, the biopharma market size is estimated to be over $400 billion, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].

Regulatory Changes

The FDA has proposed a rule to update the National Drug Code (NDC) format from 10 digits to 12 digits, aiming to minimize confusion and medication errors. This change includes a 3-year transition period to facilitate a smooth transition for all stakeholders, which could impact labeling and drug listing submissions[2].

Market Analysis

Demand and Usage

Propofol is a critical anesthetic agent used in various medical settings, including hospitals, surgical centers, and intensive care units. The demand for Propofol is consistent due to its widespread use in surgical procedures and its role in maintaining anesthesia during operations.

Competitive Landscape

The market for Propofol is competitive, with multiple manufacturers, including Dr. Reddy's Laboratories Inc., producing this drug. The competitive landscape can influence pricing strategies, as manufacturers may adjust prices to remain competitive while ensuring profitability.

Pricing Trends

Historically, drug prices have shown minimal fluctuation, with only about 1% of prices changing in most weeks. However, when changes occur, they can be significant, with median price increases around 7% and median decreases sometimes exceeding 15%[4].

Price Projections

Short-Term Projections

Given the stable demand and the competitive nature of the market, short-term price projections for Propofol Injectable Emulsion (NDC 43598-0549) are likely to remain relatively stable. Any significant price changes would be influenced by factors such as raw material costs, manufacturing efficiencies, and regulatory changes.

Long-Term Projections

In the long term, several factors could influence price projections:

  • Regulatory Changes: The transition to a 12-digit NDC format may lead to initial costs associated with relabeling and system updates, which could temporarily affect pricing. However, the long-term impact is expected to be minimal once the transition is complete[2].
  • Market Competition: Increased competition from other manufacturers could lead to price adjustments to maintain market share.
  • Technological Advancements: Improvements in manufacturing processes or the introduction of new anesthetic agents could impact the pricing strategy of Propofol.

Economic and Market Factors

The overall economic climate, including inflation rates and healthcare spending trends, will also play a role in price projections. For instance, if healthcare spending increases, manufacturers might have more flexibility to adjust prices.

Key Takeaways

  • Stable Demand: Propofol's consistent demand due to its critical role in medical procedures.
  • Competitive Market: Multiple manufacturers influence pricing strategies.
  • Regulatory Impact: Transition to 12-digit NDCs may have short-term costs but minimal long-term impact.
  • Economic Factors: General economic conditions and healthcare spending trends will influence price projections.

FAQs

What is the current market size of the biopharma industry?

The biopharma market size was estimated to be over $400 billion as of 2024, with a projected CAGR of 7.56% between 2024 and 2029[3].

How will the FDA's proposed NDC format change affect drug labeling?

The proposed rule will update the NDC format from 10 digits to 12 digits, with a 3-year transition period to minimize confusion and medication errors. This includes updating labeling and drug listing submissions[2].

What factors influence the pricing of Propofol Injectable Emulsion?

Pricing is influenced by demand, competition, regulatory changes, raw material costs, manufacturing efficiencies, and overall economic conditions.

How often do drug prices typically change?

Drug prices show minimal fluctuation, with only about 1% of prices changing in most weeks. However, when changes occur, they can be significant[4].

What is the significance of the 12-digit NDC format transition?

The transition aims to standardize NDCs, minimize confusion and medication errors, and provide certainty in date and planning for stakeholders[2].

Sources

  1. FindACode: Dr. Reddy's Laboratories Inc. - NDC Labeler/Manufacturer
  2. FDA: Future Format of the National Drug Code
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. OIG.HHS.GOV: Temporary Medicare-Approved Drug Discount Card: Analysis of Drug Prices
  5. CMS.GOV: Drug Name and National Drug Code (NDC) Reference Data Instructions

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.